BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10834715)

  • 1. Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response.
    Jeschke MG; Barrow RE; Herndon DN
    Crit Care Med; 2000 May; 28(5):1578-84. PubMed ID: 10834715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children.
    Jeschke MG; Finnerty CC; Kulp GA; Przkora R; Mlcak RP; Herndon DN
    Pediatr Crit Care Med; 2008 Mar; 9(2):209-16. PubMed ID: 18477935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human growth hormone alters acute phase reactant proteins, cytokine expression, and liver morphology in burned rats.
    Jeschke MG; Herndon DN; Wolf SE; DebRoy MA; Rai J; Lichtenbelt BJ; Barrow RE
    J Surg Res; 1999 May; 83(2):122-9. PubMed ID: 10329105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended hypermetabolic response of the liver in severely burned pediatric patients.
    Jeschke MG; Barrow RE; Herndon DN
    Arch Surg; 2004 Jun; 139(6):641-7. PubMed ID: 15197091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor modulates the hepatic acute-phase response in thermally injured rats.
    Jeschke MG; Herndon DN; Wolf SE; DebRoy MA; Rai J; Thompson JC; Barrow RE
    Crit Care Med; 2000 Feb; 28(2):504-10. PubMed ID: 10708191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human growth hormone modulates the hepatic acute-phase response and P-selectin in burned rats.
    Basoglu M; Kiziltunc A; Yildirgan MI; Gumustekin K; Gumus M; Yildirim A; Atamanalp SS
    Burns; 2002 Dec; 28(8):760-4. PubMed ID: 12464474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preventative role of growth hormone on acute liver injury induced by cardiopulmonary bypass in a rat model.
    An Y; Xiao YB
    Eur J Cardiothorac Surg; 2007 Jun; 31(6):1037-43. PubMed ID: 17498965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of growth hormone with hepatocyte growth factor alters the acute phase response.
    Jeschke MG; Wolf SE; DebRoy MA; Herndon DN
    Shock; 1999 Sep; 12(3):181-7. PubMed ID: 10485595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children.
    Spies M; Wolf SE; Barrow RE; Jeschke MG; Herndon DN
    Crit Care Med; 2002 Jan; 30(1):83-8. PubMed ID: 11902293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned children.
    Jeschke MG; Barrow RE; Herndon DN
    Ann Surg; 2000 Feb; 231(2):246-52. PubMed ID: 10674617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury.
    Klein GL; Wolf SE; Langman CB; Rosen CJ; Mohan S; Keenan BS; Matin S; Steffen C; Nicolai M; Sailer DE; Herndon DN
    J Clin Endocrinol Metab; 1998 Jan; 83(1):21-4. PubMed ID: 9435411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor I in combination with insulin-like growth factor binding protein 3 affects the hepatic acute phase response and hepatic morphology in thermally injured rats.
    Jeschke MG; Herndon DN; Barrow RE
    Ann Surg; 2000 Mar; 231(3):408-16. PubMed ID: 10714634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone treatment in pediatric burns: a safe therapeutic approach.
    Ramirez RJ; Wolf SE; Barrow RE; Herndon DN
    Ann Surg; 1998 Oct; 228(4):439-48. PubMed ID: 9790334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human growth hormone (rhGH) downregulates hepatocyte growth factor (HGF) in burns.
    Jeschke MG; Wolf SE; DebRoy MA; Jarrar D; Herndon DN
    J Surg Res; 1998 Apr; 76(1):11-6. PubMed ID: 9695731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of insulin-like growth factor-I in serum and liver after recombinant human growth hormone administration in thermally injured rats.
    Jeschke MG; Chrysopoulo MT; Herndon DN; Wolf SE
    J Surg Res; 1999 Jul; 85(1):171-7. PubMed ID: 10383855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin treatment improves the systemic inflammatory reaction to severe trauma.
    Jeschke MG; Klein D; Herndon DN
    Ann Surg; 2004 Apr; 239(4):553-60. PubMed ID: 15024317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-I/IGFBP-3 equilibrates ratios of pro- to anti-inflammatory cytokines, which are predictors for organ function in severely burned pediatric patients.
    Jeschke MG; Barrow RE; Suzuki F; Rai J; Benjamin D; Herndon DN
    Mol Med; 2002 May; 8(5):238-46. PubMed ID: 12359954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone attenuates tumor necrosis factor alpha in burned children.
    Chrysopoulo MT; Jeschke MG; Ramirez RJ; Barrow RE; Herndon DN
    Arch Surg; 1999 Mar; 134(3):283-6. PubMed ID: 10088569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns.
    Gilpin DA; Barrow RE; Rutan RL; Broemeling L; Herndon DN
    Ann Surg; 1994 Jul; 220(1):19-24. PubMed ID: 8024354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of extended growth hormone treatment after hospital discharge in pediatric burn patients.
    Przkora R; Herndon DN; Suman OE; Jeschke MG; Meyer WJ; Chinkes DL; Mlcak RP; Huang T; Barrow RE
    Ann Surg; 2006 Jun; 243(6):796-801; discussion 801-3. PubMed ID: 16772783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.